These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2383657)

  • 1. L428 cells derived from Hodgkin's disease produce E rosette-inhibiting factor.
    Katay I; Wirnitzer U; Burrichter H; von Kalle C; Schell-Frederick E; Diehl V; Schaadt M
    Blood; 1990 Aug; 76(4):791-6. PubMed ID: 2383657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Reed-Sternberg cell/lymphocyte rosette. I. Properties of rosettes formed between Hodgkin's cell lines and allogeneic lymphocytes.
    Flavell DJ; Wright DH
    Br J Cancer; 1989 Feb; 59(2):165-73. PubMed ID: 2495015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathways of adhesion in spontaneous rosetting of T-lymphocytes to the Hodgkin's cell line L428.
    Sanders ME; Makgoba MW; Sussman EH; Luce GE; Cossman J; Shaw S
    Cancer Res; 1988 Jan; 48(1):37-40. PubMed ID: 3275493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hodgkin and sternberg-reed cell antigen(s) detected by an antiserum to a cell line (L428) derived from Hodgkin's disease.
    Stein H; Gerdes J; Kirchner H; Schaadt M; Diehl V
    Int J Cancer; 1981 Oct; 28(4):425-9. PubMed ID: 6946981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test.
    Fuks Z; Strober S; Kaplan HS
    N Engl J Med; 1976 Dec; 295(23):1273-8. PubMed ID: 185517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T and B-RFC inhibiting factor in plasma from patients with active Hodgkin's disease.
    Ezdinli EZ; Simonson KL; Simonson LG; Wasser LP
    Cancer; 1979 Jul; 44(1):106-11. PubMed ID: 313239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of clonality of rosetting T lymphocytes in Hodgkin's disease by single-cell polymerase chain reaction: detection of clonality in a polyclonal background in a case of lymphocyte predominance Hodgkin's disease.
    Trümper L; Jung W; Daus H; Mechtersheimer G; von Bonin F; Pfreundschuh M
    Ann Hematol; 2001 Nov; 80(11):653-61. PubMed ID: 11757724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: Martin E. Sanders et al., Molecular Pathways of Adhesion in Spontaneous Rosetting of T-Lymphocytes to the Hodgkin's Cell Line L428.
    Flavell DJ; Wright DH
    Cancer Res; 1990 May; 50(10):3131-2. PubMed ID: 2334908
    [No Abstract]   [Full Text] [Related]  

  • 9. The B7/BB1 antigen is expressed by Reed-Sternberg cells of Hodgkin's disease and contributes to the stimulating capacity of Hodgkin's disease-derived cell lines.
    Delabie J; Ceuppens JL; Vandenberghe P; de Boer M; Coorevits L; De Wolf-Peeters C
    Blood; 1993 Nov; 82(9):2845-52. PubMed ID: 7693051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.
    van den Berg A; Visser L; Poppema S
    Am J Pathol; 1999 Jun; 154(6):1685-91. PubMed ID: 10362793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E-rosette inhibiting substance in Hodgkin's disease spleen extracts.
    Bieber MM; Fuks Z; Kaplan HS
    Clin Exp Immunol; 1977 Sep; 29(3):369-75. PubMed ID: 201408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease.
    Doussis-Anagnostopoulou IA; Talks KL; Turley H; Debnam P; Tan DC; Mariatos G; Gorgoulis V; Kittas C; Gatter KC
    J Pathol; 2002 Aug; 197(5):677-83. PubMed ID: 12210089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rearranging antigen-receptor genes in enriched Reed-Sternberg cell fractions of Hodgkin's disease.
    Cossman J; Sundeen J; Uppenkamp M; Sussman E; Wahl L; Coupland R; Lipford E; Raffeld M
    Hematol Oncol; 1988; 6(3):205-11. PubMed ID: 3402916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular protein profiles of the Hodgkin's disease cell lines L428, KM-H2 and HDLM-2: a comparative study.
    Hock BD; Hart DN
    Leuk Res; 1992; 16(3):253-63. PubMed ID: 1560674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification of TCRbeta gene rearrangements from micromanipulated single cells: T cells rosetting around Hodgkin and Reed-Sternberg cells in Hodgkin's disease are polyclonal.
    Roers A; Montesinos-Rongen M; Hansmann ML; Rajewsky K; Küppers R
    Eur J Immunol; 1998 Aug; 28(8):2424-31. PubMed ID: 9710220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen presentation by Hodgkin's disease cells.
    Fisher RI; Cossman J; Diehl V; Volkman DJ
    J Immunol; 1985 Nov; 135(5):3568-71. PubMed ID: 3876389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abundant expression of transforming growth factor-beta 1 and -beta 2 by Hodgkin's Reed-Sternberg cells and by reactive T lymphocytes in Hodgkin's disease.
    Hsu SM; Lin J; Xie SS; Hsu PL; Rich S
    Hum Pathol; 1993 Mar; 24(3):249-55. PubMed ID: 7681031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and characterization of a monoclonal antibody that binds Reed-Sternberg cells.
    Hecht TT; Longo DL; Cossman J; Bolen JB; Hsu SM; Israel M; Fisher RI
    J Immunol; 1985 Jun; 134(6):4231-6. PubMed ID: 3157756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoenzymatic assessment of interferon-gamma in Hodgkin and Sternberg-Reed cells.
    Gerdes J; Kretschmer C; Zahn G; Ernst M; Jones DB; Flad HD
    Cytokine; 1990 Jul; 2(4):307-10. PubMed ID: 2129505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker.
    Pinkus GS; Said JW
    Am J Pathol; 1988 Nov; 133(2):211-7. PubMed ID: 3263805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.